These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9283242)

  • 61. Detection of antiplatelet antibody with a platelet immunofluorescence assay.
    Kristensen AT; Weiss DJ; Klausner JS; Laber J; Christie DJ
    J Vet Intern Med; 1994; 8(1):36-9. PubMed ID: 8176661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The use of danazol in the therapy of immune-mediated disease of dogs.
    Miller E
    Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):167-9. PubMed ID: 9283241
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Recent developments in high-dose immunoglobulin therapy: therapeutic plasma exchange, autoimmune diseases].
    Kalden JR; Schranz W; Lösch G; Krapf F; Bartels O
    Beitr Infusionther Klin Ernahr; 1982; 9():48-59. PubMed ID: 6216881
    [No Abstract]   [Full Text] [Related]  

  • 64. Plasmapheresis in the management of acute systemic lupus erythematosus?
    Jones JV; Cumming RH; Bucknall RC; Asplin CM
    Lancet; 1976 Apr; 1(7962):709-11. PubMed ID: 56531
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.
    Siami GA; Siami FS
    Ther Apher; 1999 Feb; 3(1):8-19. PubMed ID: 10079800
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antibody to soluble nuclear antigens in dogs (German shepherd) with a lupus like syndrome.
    Monier JC; Schmitt D; Perraud M; Fleury C; Gioud M; Lapras M
    Dev Comp Immunol; 1978 Feb; 2(1):161-74. PubMed ID: 305866
    [No Abstract]   [Full Text] [Related]  

  • 67. Detection of immune complexes in sera of dogs with rheumatic and neoplastic diseases by 125I-Clq binding test.
    Terman DS; Moore D; Collins J; Johnston B; Person D; Templeton J; Poser R; Quinby F
    J Comp Pathol; 1979 Apr; 89(2):221-7. PubMed ID: 88464
    [No Abstract]   [Full Text] [Related]  

  • 68. Lupus-type "anticoagulant" in a dog with hemolysis and thrombosis.
    Stone MS; Johnstone IB; Brooks M; Bollinger TK; Cotter SM
    J Vet Intern Med; 1994; 8(1):57-61. PubMed ID: 8176665
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antibody to acetylcholine receptor in canine and human myasthenia gravis: differential cross-reactivity with human and rabbit receptor.
    Dau PC; Yano CS; Ettinger SJ
    Neurology; 1979 Jul; 29(7):1065-8. PubMed ID: 572937
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neoplasia and immune-mediated thrombocytopenia.
    Helfand SC
    Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):267-70. PubMed ID: 3258693
    [No Abstract]   [Full Text] [Related]  

  • 71. Autoimmune disease in the dog.
    Bennett D
    In Pract; 1984 May; 6(3):74-86, 93. PubMed ID: 6376369
    [No Abstract]   [Full Text] [Related]  

  • 72. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
    Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
    Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [THE ROLE OF AUTOANTIBODIES TO THE EXTRACELLULAR REGIONS OF IONOTROPIC RECEPTORS IN ETIOLOGY AND PATHOGENESIS OF AUTOIMMUNE DISEASES].
    Zharova OA; Shpakov AO
    Ross Fiziol Zh Im I M Sechenova; 2016 Jul; 102(7):773-91. PubMed ID: 30193046
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Indications for the application of plasmapheresis (author's transl)].
    Samtleben W; Blumenstein M; Habersetzer R; Gurland HJ
    MMW Munch Med Wochenschr; 1982 Jul; 124(27):641-5. PubMed ID: 6810157
    [No Abstract]   [Full Text] [Related]  

  • 75. [Plasma exchange in clinical practice].
    van de Wiel A; Zwaveling JH; Rommes JH; Imhof JW
    Ned Tijdschr Geneeskd; 1982 Oct; 126(40):1822-6. PubMed ID: 7144947
    [No Abstract]   [Full Text] [Related]  

  • 76. Sequential plasmapheresis and intravenous immunoglobulin therapy for refractory myasthenia gravis: case report.
    Yeh JH; Chiu HC
    Ther Apher; 1999 Aug; 3(3):271-4. PubMed ID: 10427628
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Plasmapheresis: a pediatric perspective.
    Singsen BH
    J Pediatr; 1981 Feb; 98(2):232-5. PubMed ID: 7463218
    [No Abstract]   [Full Text] [Related]  

  • 78. The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development.
    JAMA; 1986 Sep; 256(10):1333-7. PubMed ID: 3747048
    [No Abstract]   [Full Text] [Related]  

  • 79. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
    Shelton GD; Skeie GO; Kass PH; Aarli JA
    Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunoadsorption plasmapheresis for severe generalised myasthenia gravis.
    Ichikawa M; Koh CS; Hata Y; Tohyama M; Tsuno T; Komiyama A
    Arch Dis Child; 1993 Aug; 69(2):236-8. PubMed ID: 8215529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.